CATALYST PHARMACEUTICALS, INC. General and Administrative Expense in USD from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
Catalyst Pharmaceuticals, Inc. quarterly/annual General and Administrative Expense history and growth rate from Q2 2010 to Q3 2025.
  • Catalyst Pharmaceuticals, Inc. General and Administrative Expense for the quarter ending September 30, 2025 was $15M, a 0.3% increase year-over-year.
  • Catalyst Pharmaceuticals, Inc. General and Administrative Expense for the twelve months ending September 30, 2025 was $56.1M.
  • Catalyst Pharmaceuticals, Inc. annual General and Administrative Expense for 2024 was $59M, a 39.8% increase from 2023.
  • Catalyst Pharmaceuticals, Inc. annual General and Administrative Expense for 2023 was $42.2M, a 62.1% increase from 2022.
  • Catalyst Pharmaceuticals, Inc. annual General and Administrative Expense for 2022 was $26M.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)
General and Administrative Expense, Annual (USD)
General and Administrative Expense, YoY Annual Growth (%)

CATALYST PHARMACEUTICALS, INC. Quarterly General and Administrative Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $56.1M $15M +$44K +0.3% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-05
Q2 2025 $56.1M $14.8M +$2.19M +17.3% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-06
Q1 2025 $53.9M $14.8M -$5.13M -25.7% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q4 2024 $59M $11.5M Oct 1, 2024 Dec 31, 2024 10-K 2025-02-26
Q3 2024 $14.9M Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-05
Q2 2024 $12.6M Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-06
Q1 2024 $19.9M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q4 2018 $15.9M $6.93M +$4.82M +229% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-18
Q3 2018 $11.1M $3.64M +$2.04M +128% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $9.01M $2.63M +$902K +52.1% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $8.11M $2.67M +$808K +43.3% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $7.3M $2.11M +$614K +41.1% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 $6.69M $1.6M +$182K +12.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $6.51M $1.73M -$576K -25% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $7.09M $1.87M -$825K -30.7% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $7.91M $1.49M -$867K -36.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-14
Q3 2016 $8.78M $1.42M -$555K -28.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $9.33M $2.31M -$14.3K -0.62% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $9.35M $2.69M +$749K +38.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $8.6M $2.36M +$760K +47.5% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-14
Q3 2015 $7.84M $1.97M +$752K +61.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $7.08M $2.32M +$1.43M +160% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $5.66M $1.94M +$1.18M +156% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $4.47M $1.6M +$961K +150% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 $3.51M $1.22M +$782K +177% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $2.73M $891K +$370K +70.9% Apr 4, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $2.36M $760K +$147K +23.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $2.21M $639K -$122K -16% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 $2.34M $441K -$187K -29.8% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 $2.52M $521K -$13.1K -2.46% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 $2.54M $613K -$24.3K -3.81% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 $2.56M $761K -$314K -29.2% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-13
Q3 2012 $2.88M $629K +$112K +21.7% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 $2.76M $535K +$42.8K +8.7% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $2.72M $637K +$22.1K +3.59% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 $2.7M $1.07M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-19
Q3 2011 $517K +$108K +26.6% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $492K -$43.4K -8.1% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 $615K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 $408K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 $535K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15

CATALYST PHARMACEUTICALS, INC. Annual General and Administrative Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $59M +$16.8M +39.8% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-26
2023 $42.2M +$16.2M +62.1% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-26
2022 $26M Jan 1, 2022 Dec 31, 2022 10-K 2025-02-26
2018 $15.9M +$8.57M +117% Jan 1, 2018 Dec 31, 2018 10-K 2019-03-18
2017 $7.3M -$606K -7.66% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 $7.91M -$687K -7.99% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-14
2015 $8.6M +$4.12M +92.2% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-14
2014 $4.47M +$2.26M +102% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
2013 $2.21M -$347K -13.5% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 $2.56M -$137K -5.06% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-13
2011 $2.7M +$492K +22.3% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-19
2010 $2.21M Jan 1, 2010 Dec 31, 2010 10-K 2013-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.